Repligen
RGEN • NASDAQ
Repligen is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Olivier Loeillot, with a market cap of $7.5B.
Market Cap$7.5B
Employees1.8K
CEOOlivier Loeillot
CountryUnited States of America
Healthcare
Medical - Instruments & Supplies
Next EarningsMay 5, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
Repligen FAQ
Common questions about Repligen
Repligen is scheduled to report earnings for Q1 2026 on May 5, 2026 before market open. Analysts estimate revenue of $192.1M.
Repligen has approximately 1,783 employees.